(Q40331204)

19 September 2017

Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody (English)

1 reference

19 September 2017

Sun Ok Yoon

1

1 reference

19 September 2017

Tae Sup Lee

2

1 reference

19 September 2017

Sang Jick Kim

3

1 reference

19 September 2017

Myung Hee Jang

4

1 reference

19 September 2017

Young Jun Kang

5

1 reference

19 September 2017

Jae Hyun Park

6

1 reference

19 September 2017

Keun-Soo Kim

7

1 reference

19 September 2017

Hyun Sil Lee

8

1 reference

19 September 2017

Chun Jeih Ryu

9

1 reference

19 September 2017

Noreen R Gonzales

10

1 reference

19 September 2017

Syed V S Kashmiri

11

1 reference

19 September 2017

Sang Moo Lim

12

1 reference

19 September 2017

Chang Woon Choi

13

1 reference

19 September 2017

Hyo Jeong Hong

14

1 reference

19 September 2017

language of work or name

English

0 references

publication date

9 January 2006

1 reference

Journal of Biological Chemistry

19 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

19 September 2017

281

1 reference

19 September 2017

11

1 reference

19 September 2017

6985-6992

1 reference

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease

19 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Replacing the complementarity-determining regions in a human antibody with those from a mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

A humanized antibody that binds to the interleukin 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Standard conformations for the canonical structures of immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Monoclonal antibodies in the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Immunogenicity of engineered antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Anatomy of the antibody molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

CDR substitutions of a humanized monoclonal antibody (CC49): contributions of individual CDRs to antigen binding and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Minimizing immunogenicity of the SDR-grafted humanized antibody CC49 by genetic manipulation of the framework residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Generation and characterization of a humanized antibody with specificity for preS2 surface antigen of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Neutralizing human monoclonal antibodies to hepatitis A virus recovered by phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Colony lift assay using cell-coated filters: a fast and efficient method to screen phage libraries for cell-binding clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

Rationally engineered proteins or antibodies with absent or reduced immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511165200

21 January 2018

Identifiers

DOI

10.1074/JBC.M511165200

1 reference

19 September 2017

1 reference